Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Bioatla, Inc. (BCAB)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 46,110,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   BioAtla is a biopharmaceutical company engaged in developing specific and selective antibody-based therapeutics for the treatment of various cancers. Co.'s lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and other tumor types. Co. also develops BA3021, a CAB ADC for NSCLC and Melanoma; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 81,495 83,495 252,735
Total Buy Value $0 $172,540 $177,620 $814,041
Total People Bought 0 4 4 4
Total Buy Transactions 0 4 5 15
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 207
  Page 9 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Steinman Lawrence Director   –       •      –    2020-12-15 3 IO $0.00 $0 D/D 0 14,871     -
   Vasquez Christian See RemarksOfficer   •       –      –    2020-12-15 3 IO $0.00 $0 D/D 0 26,923     -
   Moran Susan Director   –       •      –    2020-12-15 3 IO $0.00 $0 D/D 0 12,307     -
   Gray Mary Ann Director   –       •      –    2020-12-15 3 IO $0.00 $0 D/D 0 12,307     -
   Short Carolyn Anderson See RemarksOfficer   •       –       •   2020-12-15 3 IO $0.00 $0 D/D 0 138,461     -
   Short Carolyn Anderson See RemarksOfficer   •       –       •   2020-12-15 3 IO $0.00 $0 I/I 0 6,789,280     -
   Waldron Richard A Chief Financial OfficerOfficer   •       –      –    2020-12-15 3 IO $0.00 $0 D/D 0 134,615     -

  207 Records found
  1  2  3  4  5  6  7  8  9    
  Page 9 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed